The DOI matches its Crossref record; 281 of the 281 references it cites were found in a registry or an index.
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–281 of 281
No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response
Bolonna, A. A., Arranz, M. J., Munro, J., Osborne, S., Petouni, M., Martínez, M. J., & Kerwin, R. W. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)01000-9 · Cited by 65
Self-citationMihara, K., Kondo, T., Suzuki, A., Yasui‐Furukori, N., Ono, S., Sano, A., Koshiro, K., Otani, K., & Kaneko, S. (2002) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10025 · Cited by 65
Tiwari, A. K., Deshpande, S. N., Rao, A. R., Triptish Bhatia, A., Mukit, S. R., Shriharsh, V., Lerer, B., Nimagaonkar, V. L., & Thelma, B. K. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500282 · Cited by 65
Impact of Myeloperoxidase and NADPH-Oxidase Polymorphisms in Drug-Induced Agranulocytosis
Mosyagin, I., Dettling, M., Roots, I., Müller-Oerlinghausen, B., & Cascorbi, I. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144891.52858.a6 · Cited by 64
Pavanello, S., Pulliero, A., Lupi, S., Gregorio, P., & Clonfero, E. (2005) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2005.08.008 · Cited by 64
The serotonin transporter and clozapine response
Arranz, M. J., Bolonna, A. A., Munro, J., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000652 · Cited by 64
Self-citationHori, H., Ohmori, O., Shinkai, T., Kojima, H., & Nakamura, J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10045 · Cited by 64
Chen, M., & Chen, C. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300612 · Cited by 63
Chong, V. Z., Young, L. T., & Mishra, R. K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01104.x · Cited by 62
Tsai, S., Wang, Y.-C., Yu, W., Lin, C., Yang, K., & Hong, C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00127-4 · Cited by 62
NQO2 gene is associated with clozapine‐induced agranulocytosis
Ostrousky, O., Meged, S., Loewenthal, R., Valevski, A., Weizman, A., Carp, H., & Gazit, E. (2003) · Tissue Antigens · doi:10.1046/j.1399-0039.2003.00133.x · Cited by 62
Tugnait, M., Hawes, E. M., McKay, G., Eichelbaum, M. F., & Midha, K. K. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00006-x · Cited by 61
Kalgutkar, A. S. S., Taylor, T. J., Venkatakrishnan, K., & Isin, E. M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.243 · Cited by 61
HLA‐B38 and clozapine‐induced agranulocytosis in Israeli Jewish schizophrenic patients
Valevski, A., Klein, T., Gazit, E., Meged, S., Stein, D. J., Elizur, A., Narinsky, E. R., Kutzuk, D., & Weizman, A. (1998) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.1998.00091.x · Cited by 60
Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins
Thomas, E. A., George, R. C., Danielson, P. E., Nelson, P. A., Warren, A. J., Lo, D. D., & Sutcliffe, J. G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001425 · Cited by 59
Berecz, R., Dorado, P., Rubia, A., Cáceres, M. C., Degrell, I., & LLerena, A. (2004) · Current Drug Targets · doi:10.2174/1389450043345263 · Cited by 59
Herken, H., Erdal, M. E., Böke, Ö., & SAVAS, H. A. (2003) · European Psychiatry · doi:10.1016/s0924-9338(03)00005-1 · Cited by 58
Smoking impact on CYP1A2 activity in a group of patients with schizophrenia
Bozikas, V. P., Papakosta, M., Niopas, I., Karavatos, A., & Mirtsou-Fidani, V. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00061-0 · Cited by 58
Müller, D. J., Luca, V. D., Sicard, T., King, N. A., Hwang, R., Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J., Citrome, L., et al. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.001 · Cited by 57
Wang, Y.-C., Bai, Y., Chen, J.-Y., Lin, C., Lai, I., & Liou, Y. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0291-7 · Cited by 57
Cytochrome P450 polymorphisms and response to antipsychotic therapy
Scordo, M. G., & Spina, E. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.2.201 · Cited by 57
Zai, G. C., Müller, D. J., Volavka, J., Czobor, P., Lieberman, J. A., Meltzer, H. Y., & Kennedy, J. L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0482-4 · Cited by 56
Fu, Y. H. H., Fan, C., Deng, H., Hu, S.-H., De-peng, L. V., Li, L., Wang, J., & Xin-qiao, L. U. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00279.x · Cited by 56
DRD3 and DAT1 genes in schizophrenia: an association study
Joober, R., Toulouse, A., Benkelfat, C., Lal, S., Bloom, D., Labelle, A., Lalonde, P., Turecki, G., & Rouleau, G. A. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00018-2 · Cited by 54
Neuregulin genotype and medication response in Finnish patients with schizophrenia
Kampman, O., Anttila, S. A. K., Illi, A., Saarela, M., Rontu, R., Mattila, K. M., Leinonen, E. V. J., & Lehtimäki, T. J. (2004) · Neuroreport · doi:10.1097/00001756-200411150-00017 · Cited by 53
Matsumoto, C., Shinkai, T., Hori, H., Ohmori, O., & Nakamura, J. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.03.011 · Cited by 52
Anttila, S., Illi, A., Kampman, O., Mattila, K. M., Lehtimäki, T. J., & Leinonen, E. V. J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0233-9 · Cited by 52
Woo, S., Kim, J., Rha, E., Han, S., Hahn, K., Park, C., & Sohn, J. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.01038.x · Cited by 52
Hernandez, A. I., & Sokolov, B. P. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000215 · Cited by 51
Zalsman, G., Frisch, A., Lev‐Ran, S., Martin, A., Michaelovsky, E., Bensason, D., Gothelf, D., Nahshoni, E., Tyano, S., & Weizman, A. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00006-3 · Cited by 50
Inada, T., Senoo, H., Iijima, Y., Yamauchi, T., & Yagi, G. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00005 · Cited by 50
Antipsychotics and dopamine transporter gene polymorphisms in delirium patients
KIM, J., Jung, I., HAN, C., CHO, S., Kim, L., KIM, S., Lee, B.-H., Lee, H., & Kim, Y. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01355.x · Cited by 50
Metabolism, Pharmacogenetics, and Metabolic Drug–Drug Interactions of Antipsychotic Drugs
Fang, J., & Gorrod, J. W. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006938908284 · Cited by 49
Ai-ling, Z., Zhao, J., Zhang, Y., Xue, Z., Chen, J., & Chen, X. (2005) · International Journal of Neuroscience · doi:10.1080/00207450590957863 · Cited by 49
Yasui‐Furukori, N., Saito, M., Nakagami, T., Kaneda, A., Tateishi, T., & Kaneko, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.019 · Cited by 49
Pae, C., Yu, H.-S., Kim, J.-J., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004419 · Cited by 48
Yu, Y. W. ‐., Tsai, S., Yang, K., Lin, C., Chen, M., & Hong, C. (2001) · Neuropsychobiology · doi:10.1159/000054871 · Cited by 48
The HapMap project and its application to genetic studies of drug response
Deloukas, P., & Bentley, D. R. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500226 · Cited by 47
Impact of haloperidol and risperidone on gene expression profile in the rat cortex
Fehér, L. Z., Kalman, J. L., Puskás, L. G., Gyülvészi, G., Kitajka, K., Penke, B., Palotás, M., Samarova, E. I., Molnár, J., Zvara, Á., et al. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.020 · Cited by 47
Tsai, S., Yu, Y. W. ‐., Lin, C., et al. (2004) · Neuropsychobiology · doi:10.1159/000077939 · Cited by 47
Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
Meltzer, H. Y., & Gudelsky, G. A. (1992) · PubMed · Cited by 46
Tsai, S., Hong, C., Yu, Y. W. ‐., Lin, C., & Liu, L. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00531-5 · Cited by 45
CYP2D6 Polymorphism and Tardive Dyskinesia in Schizophrenic Patients
Lohmann, P., Bagli, M., Krauss, H., Müller, D., Schulze, T. G., Fangerau, H., Ludwig, M., Barkow, K., Held, T., Heun, R., et al. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-39048 · Cited by 44
Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex
CHEN, M., & Chen, C. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.03.005 · Cited by 44
Olanzapine: concordant response in monozygotic twins with schizophrenia
Mata, I. F., Madoz, V., Arranz, M. J., Sham, P. C., & Murray, R. M. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.86 · Cited by 44
Self-citationDettling, M., Sachse, C., Müller-Oerlinghausen, B., Roots, I., Brockmöller, J., Rolfs, A., & Cascorbi, I. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-8359 · Cited by 43
An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201
Amar, A., Segman, R. H., Shtrussberg, S., Sherman, L., Safirman, C., Lerer, B., & Brautbar, C. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798001023 · Cited by 43
Hwang, R., Shinkai, T., Luca, V. D., Macciardi, F. M., Potkin, S. G., Meltzer, H. Y., & Kennedy, J. L. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.004 · Cited by 40
Yang, B., Son, H., Kim, S. H., NAM, J., CHOI, J., & Lee, J. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01229.x · Cited by 39
Liou, Y., Lai, I., Liao, D., Chen, J., Bai, Y., Lin, C.-C., Lin, C., Chen, T., Chen, C., & Wang, Y.-C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.04.008 · Cited by 38
Pharmacokinetic Factors in the Adverse Cardiovascular Effects of Antipsychotic Drugs
Brown, C., Farmer, R. G., Soberman, J. E., & Eichner, S. F. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443010-00003 · Cited by 38
Sondhi, S., Castellano, J. M., Chong, V. Z., Rogoza, R. M., Skoblenick, K. J., Dyck, B. A., Gabriele, J. P., Thomas, N., Ki, K., Pristupa, Z. B., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500346 · Cited by 37
Mihara, K., Suzuki, A., Kondo, T., Nagashima, U., Ono, S., Otani, K., & Kaneko, S. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000612)96:3<422::aid-ajmg35>3.0.co;2-5 · Cited by 37
Rietschel, M., Kennedy, J. L., Macciardi, F. M., & Meltzer, H. Y. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00153-4 · Cited by 36
Liou, Y., Lai, I., Lin, M., Bai, Y., Lin, C.-C., Liao, D., Chen, J., Lin, C., & Wang, Y.-C. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000184958.05775.66 · Cited by 36
Waddington, J. L., & Youssef, H. A. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.3.376 · Cited by 35
Receptor profile of antipsychotics
Leysen, J. E. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8448-8_4 · Cited by 34
Shinkai, T., Müller, D. J., Luca, V. D., Shaikh, S. A., Matsumoto, C., Hwang, R., King, N. A., Trakalo, J., Potapova, N., Zai, G. C., et al. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.023 · Cited by 34
Jauß, M., Krack, P., Franz, M., Klett, R., Bauer, R., Gallhofer, B., & Dorndorf, W. (1996) · Movement Disorders · doi:10.1002/mds.870110621 · Cited by 33
Zhang, Z., Yao, Z., Zhang, X., Chen, J., Sun, J., Yao, H., Hou, G., & Zhang, X.-B. (2003) · PubMed · Cited by 32
Lerer, B., & Segman, R. H. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.1/blerer · Cited by 31
Matsumoto, C., Ohmori, O., Shinkai, T., Hori, H., & Nakamura, J. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200412000-00008 · Cited by 30
Spotlight on Amisulpride in Schizophrenia*
Curran, M. P., & Perry, C. M. (2002) · CNS Drugs · doi:10.2165/00023210-200216030-00007 · Cited by 29
Genetic association analysis of 5-HT6 receptor gene polymorphism (267C/T) with tardive dyskinesia
Ohmori, O., Shinkai, T., Hori, H., & Nakamura, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00095-1 · Cited by 29
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing
Skarke, C., Kirchhof, A., Geißlinger, G., & Lötsch, J. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0029-3 · Cited by 29
Strous, R. D., Greenbaum, L., Kanyas, K., Merbl, Y., Horowitz, A., Karni, O., Viglin, D., Olender, T., Deshpande, S. N., Lancet, D., et al. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006651 · Cited by 27
Wang, Y.-C., Liou, Y., Liao, D., Bai, Y., Lin, C.-C., Yu, S.-C., & Chen, J.-Y. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0118-y · Cited by 26
Mihara, K., Kondo, T., Suzuki, A., Yasui, N., Ono, S., Otani, K., & Kaneko, S. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(00)00247-x · Cited by 26
Chen, A. C. H., McDonald, B., Moss, S. J., & Gurling, H. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00326-4 · Cited by 25
Furukori, H., Kondo, T., Yasui, N., Otani, K., Tokinaga, N., Nagashima, U., Kaneko, S., & Inoue, Y. (1999) · Psychopharmacology · doi:10.1007/s002130051048 · Cited by 23
Liou, Y., Wang, Y.-C., Lin, C.-C., Bai, Y., Lai, I., Liao, D., & Chen, J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005262 · Cited by 23
Kishida, I., Kawanishi, C., Furuno, T., Matsumura, T., Hasegawa, H., Sugiyama, N., Suzuki, K., Yamada, Y., & Kosaka, K. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200303000-00010 · Cited by 23
Takao, T., Tachikawa, H., Kawanishi, Y., Katano, T., Sen, B., Homma, M., Kohda, Y., Mizukami, K., & Asada, T. (2006) · Psychiatric Genetics · doi:10.1097/01.ypg.0000194441.04684.db · Cited by 19
RGS4 genotype is not associated with antipsychotic medication response in schizophrenia
Kampman, O., Illi, A., Hänninen, K., Katila, H., Anttila, S., Rontu, R., Mattila, K. M., Leinonen, E. V. J., & Lehtimäki, T. J. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0445-2 · Cited by 19
James, H. M., Coller, J. K., Gillis, D., Bahnisch, J., Sallustio, B. C., & Somogyi, A. A. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42719 · Cited by 18
Using a DNA Microarray Method to Examine Gene Expression in Brain from Clozapine‐Injected Mice
TAKAHASHI, Y., Kumanishi, T., & HAYASHI, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.069 · Cited by 17
Economic issues in access to medications: Schizophrenia treatment in England
Knapp, M. R. J., Kanavos, P. G., King, D., & Yesudian, H. M. (2005) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2005.08.007 · Cited by 14
Krebs, M. (1995) · PubMed · Cited by 12
Luca, V. D., VINCENT, J., Müller, D., Hwang, R., Shinkai, T., Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J., & Citrome, L. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.10.013 · Cited by 10
Novel and alternate SNP and genetic technologies
Breen, G. D. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200206000-00005 · Cited by 10
Investigation of the phenylalanine hydroxylase gene and tardive dyskinesia
RICHARDSON, M. A., Chao, H. M., Read, L. L., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30281 · Cited by 5
Cited by
van Os, J., Rutten, B. P., & Poulton, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn117 · Cited by 713
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 517
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427
Antipsychotic drugs and obesity
Correll, C. U., Lencz, T., & Malhotra, A. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.010 · Cited by 307
Metadata
- Authors
- Arranz, M. J., & de Leon, J.
- Venue
- Molecular Psychiatry
- Published
- 2007-06-05
- Volume
- 12
- Issue
- 8
- Pages
- 707-747
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2094769668
- Cited by
- 351
- References
- 281
- FWCI
- 39.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.